Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Journal of Cardiology|May 20, 2026
Cardiomyocyte-specific Fbxl5 deficiency promotes iron overload-driven hypercontractility and late-onset pathological hypertrophy in miceRyoko Kusaba, Keishi Miyata, Tsuyoshi Kadomatsu, et al.
Nature Communications|March 12, 2014
The serine protease prostasin regulates hepatic insulin sensitivity by modulating TLR4 signallingKohei Uchimura, Manabu Hayata, Teruhiko Mizumoto, et al.
Scientific Reports|March 17, 2015
ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signalingTetsuro Masuda, Motoyoshi Endo, Yutaka Yamamoto, et al.
European Journal of Dermatology : EJD|February 15, 2021
Existence of Staphylococcus aureus correlates with the progression of extramammary Paget's disease: potential involvement of interleukin-17 and M2-like macrophage polarizationRyoko Sakamoto, Ikko Kajihara, Tselmeg Mijiddorj, et al.
Clinical and Experimental Nephrology|December 28, 2022
Increased numbers of pre-operative circulating monocytes predict risk of developing cardiac surgery-associated acute kidney injury in conditions requiring cardio pulmonary bypassYusuke Okadome, Jun Morinaga, Yoshinori Yamanouchi, et al.
The Journal of Biological Chemistry|July 13, 2016
Mice Deficient in Angiopoietin-like Protein 2 (Angptl2) Gene Show Increased Susceptibility to Bacterial Infection Due to Attenuated Macrophage ActivityMasaki Yugami, Haruki Odagiri, Motoyoshi Endo, et al.
The Journal of Dermatology|December 31, 2025
Real-World Efficacy of Chemotherapy in Patients With Advanced Unresectable Extramammary Paget Disease: A Retrospective Multicenter Study of 138 Japanese PatientsAzusa Miyashita, Satoshi Fukushima, Koji Yoshino, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 30, 2018
Loss of Endogenous HMGB2 Promotes Cardiac Dysfunction and Pressure Overload-Induced Heart Failure in MiceMichio Sato, Keishi Miyata, Zhe Tian, et al.
European Journal of Cancer (Oxford, England : 1990)|November 8, 2021
Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation-positive non-small-cell lung cancer in a real-world setting (OSI-FACT)Yoshihiko Sakata, Shinya Sakata, Yuko Oya, et al.
Nature Communications|May 6, 2021
The lncRNA Caren antagonizes heart failure by inactivating DNA damage response and activating mitochondrial biogenesisMichio Sato, Tsuyoshi Kadomatsu, Keishi Miyata, et al.
Pageof 8